The mechanism of the cytotoxic effect exerted by parthenolide on tumor cells is not clearly defined today. This article shows that parthenolide stimulates in human osteosarcoma MG63 and melanoma SK-MEL-28 cells a mechanism of cell death, which is not prevented by z-VAD-fmk and other caspase inhibitors. In particular treatment with parthenolide rapidly stimulated (1-2 h) reactive oxygen species (ROS) generation by inducing activation of extracellular signal-regulated kinase 1/2 (ERK 1/2) and NADPH oxidase. This event caused depletion of thiol groups and glutathione, NF-kB inhibition, c-Jun N-terminal kinase (JNK) activation, cell detachment from the matrix, and cellular shrinkage. The increase of ROS generation together with the mitochondrial accumulation of Ca 2þ also favored dissipation of Dcm, which seemed primarily determined by permeability transition pore opening, since Dcm loss was partially prevented by the inhibitor cyclosporin A. Staining with Hoechst 33342 revealed in most cells, at 3-5 h of treatment, chromatin condensation, and fragmentation, while only few cells were propidium iodide (PI)-positive. In addition, at this stage apoptosis inducing factor (AIF) translocated to the nucleus and co-localized with areas of condensed chromatin. Prolonging the treatment (5-15 h) ATP content declined while PI-positive cells strongly augmented, denouncing the increase of necrotic effects. All these effects were prevented by N-acetylcysteine, while caspase inhibitors were ineffective. We suggest that AIF exerts a crucial role in parthenolide action. In accordance, down-regulation of AIF markedly inhibited parthenolide effect on the production of cells with apoptotic or necrotic signs. Taken together our results demonstrate that parthenolide causes in the two cell lines a caspase-independent cell death, which is mediated by AIF.
Parthenolide, the major bioactive sesquiterpene lactone present in Feverfew (Tanacetum parthenium), has recently attracted considerable attention because of its complex pharmacological action involving anti-microbial, antiinflammatory, and anti-cancer effects (Pareek et al., 2011) .
Due to anti-inflammatory properties and low toxicity, parthenolide is traditionally used to treat fever, headache, rheumatoid arthritis, and menstrual irregularities (Pareek et al., 2011) . Its anti-inflammatory effect depends on the ability to inhibit the transcriptional activity of nuclear factor-kB (NF-kB; Pareek et al., 2011) and the enzymatic activities of 5-lipoxygenase and cyclooxygenase (Sumner et al., 1992) , which are involved in inflammatory process.
In addition it has been shown that parthenolide may also inhibit proliferation and induce death of several human cancer cells in vitro, such as colorectal cancer (Zhang et al., 2004) , pancreatic cancer (Liu et al., 2010) , multiple myeloma (Wang et al., 2006) , prostate cancer (Sun et al., 2010) , metastatic melanoma (Czyz et al., 2010) , and cholangiocarcinoma (Kim et al., 2005) cells. In comparison with its well-established antiinflammatory activity, the anti-tumor effect of parthenolide is relatively less documented. Recent findings indicate that the drug triggers apoptosis by inhibiting the activity of the prosurvival transcriptional factor NF-kB or inducing generation of reactive oxygen species (ROS).
NF-kB is a dimeric transcription factor, which has been shown to promote survival of tumor cells and reduce the effectiveness of cancer therapy (Bours et al., 2000; Ravi and Bedi, 2004) . This factor is bound to the Inhibitor kappa B (IkB) protein in an inactive cytosolic complex. Phosphorylation of IkB leads to the release of NF-kB, which translocates into the nucleus where promotes the transcription of genes involved in inflammatory response, as well as in regulation of cell proliferation, apoptosis, and angiogenesis. Parthenolide has been shown to inhibit phosphorylation of IkB, thus leading to suppression of NF-kB activity (Kwok et al., 2001) .
Many lines of evidence indicate that parthenolide induces oxidative stress by increasing production of ROS (Wen et al., 2002; Wang et al., 2006; Zunino et al., 2007) . However, the precise mechanism of parthenolide-induced oxidative stress remains unclear, although recently it has been shown that parthenolide can increase in prostate cancer cells ROS generation by activating NADPH oxidase (NOX; Sun et al., 2010) . ROS in its turn can be responsible for alteration of mitochondrial function with the consequent activation of death signaling pathways (Hampton and Orrenius, 1998) or can induce the activation of c-Jun N-terminal kinase (JNK; Shanmugam et al., 2010 Shanmugam et al., , 2011 .
Finally, it has been ascertained that parthenolide prevents resistance of tumor cells to TRAIL. In breast cancer cells this sensitization involves activation of JNK (Nakshatri et al., 2004) , while in hepatocellular carcinoma cells parthenolide increases the surface expression of death receptors TRAIL-R1 and R2 (Carlisi et al., 2011) .
However, despite of the efficacy shown by parthenolide in the experiments in vitro, the drug exhibited in vivo only a limited activity due to its poor solubility. Recently it has been generated a dimethylamino analogue of parthenolide (DMAPT), which improves solubility and bioavailability of the drug. This compound has been employed successfully to eradicate acute myelogenous leukemia stem cells (Guzman et al., 2007) , and also prostate (Shanmugam et al., 2010) , lung and bladder (Shanmugam et al., 2011) cancer cells in vivo. These results authorize the inclusion of parthenolide in new therapeutical strategies against cancer. Consequently a detailed knowledge of the molecular mechanism induced by the sesquiterpene, either when employed alone or in association, becomes necessary.
The aim of this article was to elucidate the mechanism of parthenolide action on two lines of cancer cells, the human osteosarcoma MG63, and the melanoma SK-MEL-28 cells, on which parthenolide exerted its action inducing similar effects.
This article shows that the drug induced in the two cell lines a caspase-independent form of death. After brief treatments (1-3 h) the drug caused ROS generation, depletion of protein thiols and glutathione (GSH) and dissipation of the mitochondrial membrane potential (Dcm). These effects were accompanied by condensation and fragmentation of chromatin. For longer treatments necrotic signs became predominant together with the fall of ATP level. Nuclear translocation of apoptosis inducing factor (AIF) seemed to be the crucial event in the mechanism.
Materials and Methods

Chemicals and reagents
Parthenolide was supplied by Sigma-Aldrich (Milan, Italy) . Stock solution of parthenolide was prepared in dimethyl sulfoxide (DMSO) and diluted to final concentration in the culture medium. Final concentration of DMSO employed as vehicle never exceeded 0.04% and had no discernible effects on MG63 or SK-MEL-28 cells. All reagents were purchased from Sigma-Aldrich, except for z-VAD-fmk and DEVD-cho, which were supplied from Promega (Milan, Italy), and IETD-fmk supplied from Clontech (Palo Alto, CA).
Cell cultures
MG63 and SK-MEL-28 cells, obtained from ''Istituto Scientifico Tumori'' (Genoa, Italy), were grown as monolayers in culture medium [DMEM supplemented with 10% (v/v) FCS and 2 mM glutamine] at 378C in a humidified atmosphere containing 5% CO 2 . Cells were plated on 96 or 6-well plates or on 100-mm culture dishes, then were allowed to adhere overnight in culture medium, before the treatment with chemicals or vehicle only.
Cell viability and cell death assays
Cell viability was measured by the MTS method using the CellTiter 96 1 AQueous One Solution Cell Proliferation Assay (Promega) according to the manufacturer's protocol. Dehydrogenase activity in the mitochondria of metabolically active cells converts MTS to formazan, which is soluble in tissue culture medium. The absorbance of the formazan was measured directly at 490 nm in a 96-well plate using an automatic ELISA plate reader (OPSYS MR, Dynex Technologies, Chantilly, VA).
In order to determine either changes in nuclear morphology or plasma membrane damage, the cells were stained with Hoechst 33342 and propidium iodide (PI), as suggested by Kelly et al. (2003) . In particular, cells (6 Â 10 3 /well) were at first stained with Hoechst 33342 (2.5 mg/ml medium) for 30 min, washed with PBS, resuspended in culture medium and treated for various times with parthenolide. Then PI (2.0 mg/ml medium) was added and the incubation was protracted for additional 15 min. At the end cell morphology was visualized by a Leica DC 300F microscope (Leica microsystems, Wetzlar, Germany) using appropriate filters to examine Hoechst 33342 (DAPI filter with excitation wavelength of 372 nm and emission wavelength of 456 nm) and PI (rhodamine filter with excitation wavelength of 596 nm and emission wavelength of 620 nm). All the images were acquired by Leica Q Fluoro Software.
Apoptotic effects were also studied by flow cytometry analysis using the Annexin V-FITC/PI Apoptosis Detection Kit I (BD Biosciences Pharmingen, San Diego, CA), according to the manufacturer's instructions. Fluorescence of the cells was analyzed by a FACscan (Becton Dickinson, San Diego, CA).
Evaluation of ROS generation and mitochondrial membrane potential
For fluorimetric analysis MG63 cells (6 Â 10 3 /well) were treated for 30 min with 50 mM 5-(and-6)-carboxy-2 0 ,7 0 -dichlorodihydrofluorescein diacetate (H 2 -DCFDA) fluorescent signal (Wang and Joseph, 1999) . After washing parthenolide and other effectors were added and the cells incubated for various times. At the end the medium was removed and substituted with PBS. Fluorimetric assays were performed in a multiwell fluorescence plate reader (Varian, Palo Alto, CA). The excitation filter was set at 485 nm and the emission filter at 530 nm. In other cases fluorescence was directly visualized by means of a fluorescence microscope using a FITC filter.
In order to study the effect of parthenolide on mitochondrial membrane potential, MG63 and SK-MEL-28 cells (6 Â 10 3 /well) were treated for various times with parthenolide and other effectors. At the end cells were treated for additional 15 min with JC-1 staining solution (Cao et al., 2007) and Dcm was evaluated as indicated in the assay protocol supplied by the Cayman Chemical Company (Ann Arbor, MI). Cells were visualized by a fluorescence microscope. Healthy cells with polarized mitochondria were detected using an appropriate filter to examine J-aggregates with red-orange fluorescence (rhodamine filter with excitation wavelength of 596 nm and emission wavelength of 620 nm). Unhealthy cells were detected using a filter to examine JC-1 monomers with green fluorescence (FITC filter with excitation wavelength of 485 nm and emission wavelength of 530 nm).
For all determinations fluorescence was visualized by means of a Leica DC 300F microscope (Leica microsystems), using the Leica Q Fluoro Software.
Measurement of intracellular thiols and glutathione
In order to measure intracellular thiols, cells after the treatment were detached, washed in PBS, and resuspended in 30 mM TrisHCl, 3 mM EDTA, pH 8.2. For determination of protein thiols (Zhang et al., 2004) aliquots were added to 25 ml of 1.5 mM DTNB (Ellman's reagent) and 400 ml methanol. After centrifugation at 3,000g for 5 min, 250 ml of each supernatant were transferred in a 96-well plate and read at 412 nm. For the analysis of free thiol groups, aliquots were incubated with 25 ml 10% TCA and centrifuged. Fifty microliters of each supernatant were transferred in a 96-well plate in the presence of 200 ml 0.2 M Tris-HCl, pH 8.9 and 20 ml DTNB. Then the samples were read at 412 nm. The absorbance was determined by an automatic ELISA plate reader. The final content of intracellular thiols was expressed as nanomoles of SH groups per 10 5 cells.
The intracellular GSH concentration was measured using a commercial assay, provided by OXIS Research (Portland, OR). After treatment, the cells (2 Â 10 5 /well) were harvested, and centrifuged at 1,000g for 8 min. The pellets were washed in PBS and resuspended in 50 ml metaphosphoric acid (5 g/100 ml distilled water). GSH content was measured as described by manufacturer's instructions. Absorbance was read at 400 nm in a 96-well plate reader. The content of intracellular GSH was expressed as nanomoles of GSH per 10 5 cells.
NF-kB assay NF-kB activity was evaluated by an ELISA-based assay (Trans-AM NF-kB; Active Motif, Carlsbad, CA) as described by manufacturer's protocol. Briefly, nuclear extracts were prepared as previously reported (Carlisi et al., 2011) . Aliquots were placed in 96-well plates pre-coated with the oligonucleotide containing the NF-kB consensus sequence, and NF-kB activity was detected using a specific antibody for p65 subunit provided by the kit.
Western blotting analysis
Cell lysates were prepared as previously reported (Giuliano et al., 1999) . Protein samples (30 mg/lane) were subjected to SDS polyacrylamide gel electrophoresis and then transferred to a nitrocellulose membrane for the detection with specific antibodies. Analyses of phospho-JNK, Cytochrome c oxidase (COX IV) and histone H1 were performed by using specific antibodies produced by Santa Cruz Biotechnology (Santa Cruz, CA) while antibody for AIF was provided by Abcam (San Francisco, CA). All the others antibodies were purchased from Cell Signaling Technology (Beverly, MA). Protein bands were detected by the Enhanced chemiluminescence reagent (Pierce, Rockford, IL) and their intensity was quantified by using Quantity One quantification analysis software (Bio-Rad, Hercules, CA). The correct protein loading was ascertained by means of both red Ponceau staining and immunoblotting for b-actin. All the blots shown are representative of at least three separate experiments.
Measurement of adenosine triphosphate
Intracellular ATP was measured by using the ATP colorimetric/ fluorimetric assay kit supplied by Abcam. Cells (2 Â 10 5 /well) were lysed in 100 ml of ATP assay buffer; then 10 ml of 2 N perchloric acid were added in order to remove proteins, followed by 20 ml of buffer containing 5 M KOH and 3 M KHCO 3 . After centrifugation for 2 min at 15,000g, 20 ml of the supernatant were transferred to 96-well plate and developed according to the manufacturer's instructions. The absorbance was read at 570 nm using an automatic ELISA plate reader.
Measurement of calcium level
Cytosolic calcium level was measured using Fluo-3AM (SigmaAldrich; Zhang et al., 2004) . Cells (2 Â 10 5 /well) were collected, washed twice with cold calcium-free PBS and then incubated with 5 mM Fluo-3AM for 60 min at 378C in darkness. Then the cells were analyzed by flow cytometry on a Beckman Coulter Epics XL flow cytometer (Brea, CA) using the Expo32 software.
Detection of cytochrome c and AIF Cells (7 Â 10 6 /100-mm culture dish) were washed twice in PBS, resuspended in lysis buffer (20 mM Hepes, pH 7.5, 250 mM sucrose, 1.5 mM MgCl 2 , 10 mM KCl, 1 mM EGTA, 1 mM EDTA, 1 mM PMSF, and protease inhibitors) and homogenized with a Teflon homogenizer. In order to perform subcellular fractionation homogenates were centrifuged at 1,000g for 10 min at 48C. The pellet was used to prepare the nuclear fraction (Carlisi et al., 2008) . The supernatant was centrifuged again at 10,000g for 30 min; the resulting pellet represented the mitochondrial fraction, while the supernatant obtained, after a new centrifugation at 100,000g for 1 h at 48C, represented the cytosolic fraction. The pellets for nuclear and mitochondrial fractions were lysed and sonicated. Aliquots of mitochondrial and cytosolic fractions were used to measure the level of cytochrome c by an ELISA kit (Abnova, Taipei, Taiwan) according to the manufacturer's instructions. The absorbance was read at 450 nm using an automatic ELISA plate reader. The content of AIF was ascertained by western blotting analysis using 30 mg of proteins of the mitochondrial and nuclear fractions (Arnoult et al., 2002) . COX IV and histone H1 were used as mitochondrial and nuclear markers, respectively.
In order to study the intracellular localization of AIF, cells (6 Â 10 3 /well) were at first treated with Hoechst 33342 (2.5 mg/ml medium) and then incubated with parthenolide for the established times. At the end the cells were fixed for 5 min with 3% paraformaldehyde, permeabilized for 5 min with 0.1% Triton X-100 and incubated with a blocking solution (PBS containing 1% BSA) for 1 h at room temperature and then with rabbit monoclonal antihuman AIF antibody (Abcam) (1:100 in PBS) overnight at 48C, followed by 2 h with 1:100 dilution of FITC-conjugated secondary antibody (Santa Cruz Biotechnology). Finally, cells were visualized with a Leica DC300F microscope with DAPI filter (excitation wavelength of 372 nm and emission wavelength of 456 nm) and FITC filter (excitation wavelength of 485 nm and emission wavelength of 530 nm) for Hoechst and AIF, respectively.
Down-regulation of AIF by short interfering RNA (siRNA)
Cells were plated in a 6-well plate (7.5 Â 10 4 cells/well) and cultured in DMEM supplemented with 10% FBS for 24 h to reach approximately 60-80% confluence before transfection. For silencing experiments, a specific siRNA directed against human AIF (Santa Cruz Biotechnology) as a pool of double-stranded RNA oligonucleotides was used. Briefly, cells were transfected for 6 h with 80 nM AIF siRNA in the presence of 5 ml Metafectene Pro (Biontex, Munich, Germany) in a final volume of 1 ml serum-free DMEM. At the end, the reaction was stopped replacing the culture medium with DMEM þ 10% FCS. Cells were examined for AIF down-regulation and other properties 18 h after transfection. A scramble siRNA was used as negative control.
Statistical analysis
Results are presented as means AE standard error. Data were analyzed using the Student's t-test.
Results
Parthenolide decreases cell viability and induces cell detachment
Some preliminary experiments were performed to ascertain the dose and the time dependence of the effect exerted by parthenolide on the viability of MG63 and SK-MEL-28 cells. To this end cells were treated for different times (2-15 h) with various doses (10-100 mM) of parthenolide and the viability was assessed by MTS assay. The dose-dependence, studied at 15 h of treatment (Fig. 1A) , showed that the cytotoxic effect appeared at 10 mM parthenolide, when cell viability decreased by 15% and 25% for MG63 and SK-MEL-28 cells, respectively. Then viability diminished with the dose of parthenolide so that at 25 mM viable cells lowered in the two lines to 25% and 15% of the control values. Afterwards viability declined more slowly, reaching at 100 mM parthenolide values of about 20% and 10% of the controls. Therefore, the dose of 25 mM was chosen for all the experiments performed to investigate about the various effects induced by parthenolide. The time course study (Fig. 1B) showed that treatment with 25 mM parthenolide rapidly reduced cell viability and at 5 h of treatment the number of viable cells fell to about 32% for MG63 cells and 19% for SK-MEL-28 cells with respect to the related controls. Then viability declined more slowly with the time, reaching at 15 h values of about 25% and 15% of the controls. The addition of 100 mM z-VAD-fmk was ineffective in both cell lines, whatever was the time and the dose employed, while parthenolide effect was totally abolished by the addition of 2 mM N-acetylcysteine (NAC).
Other preliminary experiments were performed to evaluate morphological changes induced by parthenolide in MG63 and SK-MEL-28 cells. Control cells displayed under light microscopy ( Fig. 1C ) an adhesive and widened morphology. Treatment for 2 h with 25 mM parthenolide induced detachment of a large percentage of cells (70-75%). Moreover cells deprived of anchorage assumed soon a rounded shape. Prolonging the time of treatment (4 h) most of cells showed a remarkable reduction in cell volume. It is interesting to note that when 2 mM NAC was added together with parthenolide, both MG63 and SK-MEL-28 cells maintained the adhesive morphology. Therefore, NAC prevented cell detachment and the successive shrinkage.
Fluorescence microscopy and flow cytometric analysis of parthenolide effects
In order to ascertain the mode of cell death induced by parthenolide in MG63 and SK-MEL-28 cells we analyzed by fluorescence microscopy the effects of the drug in cells stained with Hoechst 33342 and PI.
Hoechst 33342 penetrates the plasma membrane and emits blue fluorescence when bound to DNA. Therefore, cells showing chromatin condensation (CC) in their nuclei have stronger blue fluorescence when compared to control cells (Kelly et al., 2003) . Instead PI is a cell-impermeable nuclear dye which stains the nuclei of the cells (red fluorescence) that have lost plasma membrane integrity and are considered to be necrotic. Figure 2A shows merged images at 100Â magnification related to the effects induced by parthenolide treatment at 3 and 12 h in both cell lines. Higher magnification (400Â) of MG63 cells permitted to observe (Fig. 2B ) at 3 h of treatment the presence of PI-negative cells which exhibited positivity to Hoechst, nuclear shrinkage and CC. In addition many of these cells also exhibited chromatin fragmentation. At 12 h of treatment a high percentage of cells showed pink fluorescence since the loss of membrane integrity allowed PI to enter the cells, which therefore were stained with both the dyes. Identical observations were made for SK-MEL-28 cells (not shown).
Time course experiments performed for both cell lines (Fig. 2C) showed that in the first phase of treatment (0-5 h) the number of cells, which exhibited brilliant blue fluorescence and chromatin condensation (CC cells), rapidly rose, reaching at 5 h a percentage of about 85%. Instead in this phase only a limited number of cells appeared positive to PI (15-25% at 5 h). Prolonging the time of treatment (5-15 h) the number of PIpositive cells showing pink fluorescence (PF cells) progressively increased so that at 15 h PF cells reached 60% and 72% of the total cells counted in the field for MG63 and SK-MEL-28 cells, respectively.
The modifications induced by parthenolide treatment in both cell lines were not prevented by the addition of 100 mM z-VADfmk, a general inhibitor of caspases ( Fig. 2A) , or other caspase inhibitors, such as DEVD-cho (100 mM) or IETD-fmk (10 mM) (not shown), whatever was the time of treatment. Instead our results show that 2 mM NAC abolished parthenolide effects during 15 h of treatment (not shown).
In addition we evaluated, using Annexin V-FITC/PI staining method, whether the cytotoxic action of parthenolide was associated with the exposure of phosphatidylserine on the cell membrane. For these experiments cells were treated for various times (5, 8, 12 , and 15 h) with 25 mM parthenolide. Then, 5 Â 10 3 cells per sample were analyzed by FACscan flow cytometer. As shown in Figure 3 , treatment for 5 h did not increase in both cell lines the percentage of cells with early apoptotic signs (C4 area). Prolonging the time of treatment the population of cells that underwent necrosis (PI-positive cells, C1 area) was progressively increased, reaching at 15 h levels of about 53% and 60% for MG63 and SK-MEL-28 cells, respectively (Fig. 3) .
Parthenolide stimulates ROS generation
To find the cause of the rapid inhibitory action exerted by parthenolide on cell viability we examined the effect of the drug on the production of ROS in the two cell lines. As shown in Figure 4A , fluorimetric assays demonstrated that parthenolide rapidly induced production of ROS. Treatment with 25 mM parthenolide stimulated in both cell lines ROS generation already at 30 min of treatment, while the maximum effect was observed at 2 h.
In agreement with this finding also fluorescence microscopy showed that parthenolide rapidly induced ROS generation in a high percentage of treated cells. In fact, as shown in Figure 4B , most of MG63 cells, pre-treated with the fluorochrome H 2 -DCFDA, exhibited green fluorescence already at 1 h of treatment with parthenolide. Identical results were obtained for SK-MEL-28 cells (not shown).
Parthenolide effect on ROS generation was inhibited by a treatment with different antioxidants, NAC, apocynin, diphenyleneiodonium (DPI), and rotenone (Fig. 4B,C) . NAC is an effective scavenger for free radicals. Apocynin and DPI prevent the production of superoxide anion through the inhibition of NOX (Wu et al., 2008) , whereas rotenone is known to reduce the production of ROS by inhibiting the mitochondrial electron transport system (Batandier et al., 2006) . Such an effect of parthenolide was also diminished by the inhibitor of extracellular signal-regulated kinase 1/2 (ERK 1/2) U0126 (Dewas et al., 2000; Satoh et al., 2000) . ERK 1/2 is a kinase which has been shown to enhance NOX-1 transcription (Moon et al., 2010) . Moreover our article demonstrates, according to previous reports of other authors , that brief treatments (1-4 h) with parthenolide stimulated in both cell lines phosphorylation and activation of ERK 1/2 (Fig. 4D) . Therefore, it seems likely that also U0126 can inhibit parthenolide effect on ROS generation through a reduction of NOX activity.
The results of our experiments for both cell lines show (Fig. 4B,C) that NAC was the most effective inhibitor, since it annulled parthenolide effect on ROS generation. At 1 h of treatment the highest effect, apart from NAC, was exerted by apocynin and DPI, which reduced the cells showing green fluorescence by 60%, followed by U0126 (À45%), and rotenone (À40%). However this last compound was shown to be more effective than apocynin, DPI, and U0126 when the cells were treated with parthenolide for longer periods of time (4 h, Fig. 4C ). At last ROS generation was not prevented by caspase inhibitors (not shown).
Finally, we investigated whether ROS generation can be correlated with the activation of autophagic mechanism. To test this possibility cells were treated with parthenolide and then incubated with 50 mM monodansylcadaverine (MDC) in PBS at 378C for 15 min. At the end the medium was replaced with PBS and the cells were analyzed by fluorescence microscopy. The analysis suggested that parthenolide did not induce the production of autophagic vacuoles in both cell lines (not shown). Therefore, it seems that autophagy is not involved in parthenolide-induced cell death.
Parthenolide causes depletion of intracellular thiols
The finding that parthenolide rapidly caused ROS generation suggested to us, in accordance with Zhang et al. (2004) , that the drug through the production of ROS can induce a depletion of SH groups. Therefore, we examined the effect of parthenolide on the intracellular levels of protein thiols, free thiols, and free GSH in both MG63 and SK-MEL-28 cells. Time course experiments (Fig. 5A ) showed that these levels rapidly diminished with the time so that in MG63 cells at 3 h of treatment the content of protein thiols was reduced to about 30% of the control, while free thiols and GSH decreased to only 14% and 10%, respectively. Similar results were found for SK-MEL-28 cells. Low doses of NAC (150 mM) completely prevented the cells of both the lines from the depletion of intracellular thiols (Fig. 5B) and GSH (not shown), while both apocynin and U0126 as well as rotenone exhibited partial preventive effects (Fig. 5B) .
The effects of parthenolide on NF-kB and JNK activities
Several lines of evidence suggest that NF-kB induces the expression of target genes that regulate apoptosis and facilitate survival of tumor cells as well as angiogenesis and metastasis. Therefore the inhibition of NF-kB in cancer cells represents one of the major strategies in anticancer therapy (Olivier et al., 2006) . Furthermore, it has been established that JNK plays a role in cell death induced by oxidative stress. Finally many authors have shown that parthenolide in several tumor cells inhibits NF-kB activity and induces JNK activation (Shanmugam et al., 2010 (Shanmugam et al., , 2011 . On the basis of these considerations we investigated whether the drug exerted any effect on NF-kB and JNK activities in MG63 and SK-MEL-28 cells. Time course experiments showed that 25 mM parthenolide markedly decreased the DNA-binding activity of p65, a component of NFkB, in both cell lines (Fig. 6A) . Parthenolide effect was very rapid since after 2 h of incubation the level of p65 activity lowered to only 20% of control. Moreover, as shown in Figure 6C , parthenolide stimulated in both cell lines phosphorylation and activation of JNK. The effect was observed already at 2 h and increased at 5 h of treatment. It is interesting to note that 2 mM NAC completely prevented both the depletion of p65 activity (Fig. 6B ) and the activation of JNK (Fig. 6C) .
The effect of parthenolide on mitochondrial membrane potential It is well known that mitochondrial permeability transition pore (PTP) is located at the inner mitochondrial membrane. Opening of this pore, as a consequence of oxidation of redox-sensitive components, results in mitochondrial permeability transition and dissipation of mitochondrial membrane potential (Dcm). It is well known that PTP is constituted by adenine nucleotide translocase (ANT) in the inner membrane (Crompton, 1999) and cyclophilin D (Cyp D) in the matrix (Crompton, 1999; Baines et al., 2005) . Cyp D induces PTP opening, favoring conformational change dependent on Ca 2þ , whereas the inhibitor of pore opening cyclosporin A (CsA) interacts with Cyp D reducing sensibility of pore opening to Ca 2þ Javadov et al., 2009) . Furthermore, the voltage-dependent anion channel (VDAC) is located in the outer mitochondrial membrane. Oligomerization of VDAC and the successive interaction with Bax can induce the production of pores permeable to apoptotic factors (Scharstuhl et al., 2009; Shoshan-Barmatz et al., 2010) . Such an event can be inhibited by 4,4 0 -diisothiocyanostilbene-2,2 0 -disulfonic acid (DIDS), as reported by Keinan et al. (2010) . 
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The findings that parthenolide stimulated ROS generation and caused depletion of intracellular thiols suggested to us, in agreement with Wen et al. (2002) , that the drug can induce dissipation of Dcm. Therefore, we studied the effect of parthenolide on Dcm by using the fluorescent cationic dye JC-1. To this end MG63 and SK-MEL-28 cells were treated with 25 mM parthenolide for various times and then with JC-1 for additional 15 min. At the end fluorescence was visualized by a Leica microscope. It was possible to observe that after brief treatments (1-3 h) JC-1 fluorescence shifted from red-orange (J-aggregates) to green (JC-monomer form), indicating dissipation of Dcm (Fig. 7A) . Figure 7B shows a time course experiment concerning the effect of parthenolide on MG63 and SK-MEL-28 cells. Dcm was expressed as a ratio between cells with brilliant red fluorescence (J-aggregates) and cells with brilliant green fluorescence (JC-1 monomers) (red/green fluorescence). In the presence of parthenolide this ratio rapidly lowered to about 20% of control at 1 h and 10% at 2 h of treatment. Such an effect was prevented by the addition of 2 mM NAC (Fig. 7C) . Moreover 10 mM CsA partially prevented parthenolide- The effect of NAC, apocynin, U0126, and rotenone on the depletion of protein thiols induced in MG63 and SK-MEL-28 cells by treatment for 2 h with parthenolide. Protein thiols, free thiols, and free GSH were determined using colorimetric assays, as reported in Methods Section. Values are the means of three independent experiments W SE.
M P < 0.01 versus untreated control.
induced depolarization, increasing the ratio ''red/green fluorescence'' from 10% to 50% of control, while a minor effect was exerted by 300 mM DIDS. These results (Fig. 7A,C ) strongly suggested that parthenolide-induced depolarization can be considered as a consequence of events primarily determined at the inner mitochondrial membrane. Because it has been suggested that mitochondrial Ca 2þ accumulation plays a role in the induction of PTP opening, we examined the effect of RU360, a selective inhibitor of the mitochondrial calcium uptake system (Garcia-Rivas et al., 2006) . As reported in Figure 7C , 10 mM RU360 partially prevented parthenolide-induced depolarization. Therefore, we concluded that dissipation of Dcm was favored by calcium overload.
Finally, parthenolide effect on Dcm was not prevented by caspase inhibitors (not shown).
The effects of parthenolide on ATP and cytosolic calcium level
The effect exerted by 25 mM parthenolide on the intracellular ATP content was studied in both MG63 and SK-MEL-28 cells during 15 h of treatment (Fig. 8A) . Until the fifth hour of treatment ATP level was not modified by the drug. Then ATP content progressively decreased and at 15 h of treatment the level of ATP, expressed as nmol/100 mg of protein, lowered in MG63 cells from the value of 3.5 in the untreated control to 0.7 in treated cells (À80%). Similarly in SK-MEL-28 cells ATP level diminished from the value of 2.2 in the control to only 0.4 in treated cells (À82%). As shown in Figure 8B , treatment with 25 mM parthenolide induced a remarkable increase in the level of cytosolic calcium both in MG63 and SK-MEL-28 cells. The effect was very rapid because was observed already at 1 h of treatment.
Parthenolide induces mitochondrial release of cytochrome c and decreases the expression of pro-caspases-3 and 8
A consequence of Dcm dissipation in the mechanism of apoptosis is the release from mitochondria of some proteins, such as cytochrome c, AIF or Smac/DIABLO. It is well known that cytochrome c, when is released into the cytosol interacts with APAF-1, pro-caspase-9 and dATP to form the apoptosome (Reubold and Eschenburg, 2012) . This complex activates caspase-9, which in turn activates the effector caspase-3. Since parthenolide caused disruption of mitochondrial membrane potential, we performed some experiments to ascertain whether the drug stimulated the release of cytochrome c. MG63 and SK-MEL-28 cells were treated for 3 h with 25 mM parthenolide. At the end the cells were homogenized and the subcellular fractions were prepared as reported in Methods. By means of an ELISA assay it was possible to demonstrate that parthenolide increased the content of cytochrome c in the cytosolic fraction while a concomitant decrement was observed in the mitochondria (Fig. 9A) .
We investigated by means of western blotting analysis whether parthenolide exerted some effects on the expression of pro-caspases and on the production of their active forms. As shown in Figure 9B , parthenolide treatment markedly decreased in both cell lines the level of both pro-caspase-8 and pro-caspase-3. These effects were already observed at 3 h of treatment and became more consistent at 5 h. Instead the level of pro-caspase-9 was not modified. Antibodies employed for this analysis detect both the full-length forms of caspases and the active fragments resulting from cleavage. However, for the three caspase activities it was not possible to observe the production of the cleaved and active forms not only at 3 and 5 h (Fig. 9B ), but also when the treatment was prolonged to 10 and 15 h (not shown).
Parthenolide induces mitochondrial release of AIF and its co-localization with DNA
It is well known that AIF is a caspase-independent death effector (Baritaud et al., 2010) , which after mitochondrial release translocates to the nucleus, where induces CC and DNA fragmentation (Jin and El-Deiry, 2005) . Therefore, we performed some experiments in order to ascertain whether parthenolide stimulates the release of AIF from mitochondria. Western blotting analysis showed that after 3 h of treatment with 25 mM parthenolide AIF level decreased in the mitochondria while it increased in the nuclear fraction (Fig. 10A) . These results suggested that parthenolide determined as a consequence of mitochondrial depolarization the release of both cytochrome c and AIF.
Then we investigated whether parthenolide treatment stimulated co-localization of AIF with DNA. The cells were stained with Hoechst 33342 for DNA and with an anti-AIF antibody suitable for the detection of endogenous AIF. In untreated cells AIF was clearly localized in extranuclear sector, whereas in parthenolide-treated cells AIF migrated to the nucleus and co-localized with areas of condensed chromatin. Figure 10B shows co-localization of AIF with DNA, which was observed after treatment for 3 h with 25 mM parthenolide either in MG63 and SK-MEL-28 cells. These results were not modified by the addition of 100 mM z-VAD-fmk (not shown).
Transfection of cells with AIF siRNA reduces the cytotoxic effects induced by parthenolide
In order to ascertain whether AIF takes part in the cytotoxic effect exerted by parthenolide we have transiently transfected both MG63 and SK-MEL-28 cells with AIF siRNA. After transfection for 6 h the incubation was protracted for other 18 h. Western blotting analysis (Fig. 11A ) revealed that this procedure caused down-regulation of AIF, which diminished by about 70% in both MG63 and SK-MEL-28 cells, while AIF level remained constant in the control cells, which were transfected with scramble siRNA.
When AIF-silenced cells of both the lines were treated for 2-4 h with 25 mM parthenolide a minor number of cells (À40 to 50%) with condensed chromatin (CC cells) was observed in comparison with control cells transfected with a scramble siRNA (Fig. 11B) . Similarly after longer periods of treatment (10-15 h) the percentages of cells exhibiting PF diminished in AIF-silenced cells with respect to the controls (Fig. 11B) . The results suggested that AIF can be considered as an effective mediator of parthenolide action.
Discussion
Although many authors have investigated about the antitumor action of parthenolide, the modalities through which this drug induces cell death are not clearly defined at the moment.
It is well known that cell death can be determined by two different mechanisms, apoptosis or necrosis. Apoptosis (Jin and El-Deiry, 2005 ) is an active process of programmed cell death, which can be triggered in tumor cells by a number of different stimuli, such as stimulation of death receptors, DNA damage and oxidative stress. Apoptosis displays cell shrinkage, CC and fragmentation, production of apoptotic bodies, and sequential activation of multiple caspases. Instead classic necrosis (Golstein and Kroemer, 2007 ) is a passive process, 
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characterized by disruption of cellular plasma membrane and extensive cellular swelling. Recently it has been shown that also necrosis can be considered as a programmed mechanism of cell death (Artus et al., 2010; Baritaud et al., 2010) , but independent on caspase activities. However, at the moment a distinction between apoptosis and necrosis on the basis of the dependence on caspase activities is not certain, because other caspaseindependent mechanisms of programmed cell death have been recently described, some of which exhibit necrotic-like aspects, whereas others show apoptotic-like characteristics (Tait and Green, 2008) .
Although previous studies report that parthenolide induces cell death in a number of tumor cells by a caspase-dependent mechanism (Steele et al., 2006; Liu et al., 2010) , our article shows for the first time that parthenolide stimulated in human osteosarcoma MG63 and melanoma SK-MEL-28 cells a caspaseindependent mechanism. In particular parthenolide induced in the first phase of treatment (0-5 h) in most of cells of both the lines condensation of chromatin while only a few cells were PIpositive. Moreover, cells assumed a rounded shape, showed a substantial reduction of their volume and appeared detached from substrate. In the second phase of treatment (5-15 h) a progressive increase in the percentages of PI-positive cells was observed, suggesting that extensive damage of cellular plasma membranes occurred only after long periods of treatment. All these events depended on oxidative stress because were prevented by NAC, whereas they were caspase-independent since z-VAD-fmk and other caspase inhibitors were unable to modify them.
Our results suggest that oxidative stress played a central role in both cell lines in the mechanism of parthenolide action. The drug strongly induced ROS generation already in the first 2 h of treatment. Such an effect, in accordance with Sun et al. (2010) , was primarily dependent on the activation of NOX, since it was efficaciously prevented by apocynin and DPI. The role of mitochondrial respiratory chain was predominant at 4 h of treatment, when rotenone resulted to be the best inhibitor of parthenolide effect.
In the first hours of treatment ROS generation was responsible for a series of events which caused toxic effects in the cells. In particular parthenolide induced in both cell lines a marked depletion of the intracellular level of free thiols, protein thiols, and free GSH. Furthermore, the drug reduced cellular adhesion to the matrix, favoring the detachment and the successive shrinkage of the cells; inhibited the binding of p65, a component of NF-kB, to DNA and caused phosphorylation and activation of JNK. The conclusion that all these events were determined by oxidative stress was supported by the evidence that they were prevented by the addition of anti-oxidants. Moreover our conclusion was in agreement with the following considerations: First, it is well known that ROS can oxidize protein thiols (Zhang et al., 2004) while GSH depletion can occur as a consequence of the involvement of GSH peroxidase activity in the scavenge of ROS and other free radicals. Second, ROS generation has been shown to inhibit adhesion of mesenchymal stem cells (Song et al., 2010) and to induce cellular shrinkage of Ehrlich ascites cells by activating KCl cotransport (Lambert et al., 2009 ). Third, it has been suggested that ROS generated by parthenolide can disrupt the NF-kB DNA binding by either direct reactions or altering intracellular redox (Shanmugam et al., 2010) . Fourth, ROS can mediate JNK activation inducing either apoptosis or necrosis (Shen and Liu, 2006; Shanmugam et al., 2010) .
In addition it is interesting to note that oxidative stress and in particular oxidation of both protein thiols (Petronilli et al., 1994; McStay et al., 2002) and GSH (Costantini et al., 1996; Halestrap et al., 1998) are involved in the control of mitochondrial membrane potential, favoring the opening of the PTP in the inner mitochondrial membrane with the consequent mitochondrial depolarization. In accordance our results show that mitochondrial depolarization was completely abrogated by NAC.
PTP plays a crucial role in the regulation of the decisive events for the fate of the cells occurring in mitochondria, such as production of ATP, calcium homeostasis, and programmed cell death. PTP opening permits the passage of solutes with low molecular weight into the matrix. Consequently the osmotic pressure increases leading to the swelling of the matrix with the rupture of the outer membrane and the passage of apoptotic factors into the cytoplasm . Instead the inner membrane remains intact since it is larger than the outer membrane. Furthermore, apoptotic factors can be also released through VDAC after its oligomerization and interaction with Bax. In this article mitochondrial membrane potential (Dcm) was studied by using the fluorescent dye JC-1, which undergoes polymerization when Dcm is high. Our results showed that parthenolide caused depolarization of mitochondrial membrane. The effect was very rapid, since after 1-2 h of treatment, the ratio ''red fluorescence to green fluorescence,'' which is in correlation with the polymerization degree of JC-1, lowered to only 10-20% of the control value. Mitochondrial depolarization was prevented by CsA, an inhibitor of PTP opening (Javadov et al., 2009) . Therefore PTP opening with the consequent rupture of the outer mitochondrial membrane seemed to be an important event in the depolarization of mitochondrial membrane induced by parthenolide. However, we concluded that also VDAC can be involved in the dissipation of membrane potential, since depolarization was also reduced by the inhibitor of VDAC DIDS, although DIDS effect was minor than that observed with CsA.
Furthermore our results suggest that a role in mitochondrial depolarization is also exerted by calcium overload since the loss of Dcm was partially prevented by RU360, an inhibitor of the influx of Ca 2þ into mitochondria. It has been suggested that the extent of PTP opening is fundamental to determine the modality of cell death. In fact transient opening could be responsible for mitochondrial swelling and the release of apoptotic factors, such as cytochrome c and AIF, while ATP concentration can be not affected. Instead extensive and persistent opening could lead to a substantial ionic disturbance with the loss of ATP, activation of degradative enzymes, and cellular necrosis (McStay et al., 2002 ). Our results demonstrate that after treatment with parthenolide for 3-5 h most of cells were positive to Hoechst and showed CC, while ATP concentration was not modified. Instead mitochondrial depolarization for longer periods of treatment (10-15 h) induced the fall in ATP content and consequently the predominance of the necrotic signs. Therefore most of cells exhibited PF, since they were positive to both Hoechst and PI.
An important consequence of parthenolide-induced depolarization of mitochondrial membrane consists in the release of cytochrome c and/or AIF. Cytochrome c is usually the responsible for the activation of caspase-dependent apoptosis, while AIF mediates the activity of caspaseindependent program. This article shows that treatment with parthenolide for 3 h induced the release from mitochondria of both cytochrome c and AIF. Cytochrome c, when is released into the cytosol, causes the production of apoptosome with the consequent activation of the initiator caspase-9, which in turn stimulates the downstream caspase cascade. However, in our experimental conditions although cytochrome c was released from mitochondria the activation of caspase cascade did not occur. This conclusion is based on the following findings: western blotting analysis showed that parthenolide decreased the level of pro-caspases-8 and -3 already after brief periods of treatment, while the cleaved and active forms of caspases-8, -9, and -3 were not produced during the entire treatment; the decrement of ATP caused by parthenolide in the second period is in contrast with the production of apoptosome; z-VAD-fmk and other caspase inhibitors did not exert any effect on the cytotoxic action of parthenolide. In addition our results are in agreement with other reports showing that caspase activities are strongly inhibited by oxidative stress (Samali et al., 1999) . Finally it has been reported that ERK 1/2, a kinase which is activated by parthenolide, can suppress caspase-9 activity by direct phosphorylation of an inhibitory site, Thr 125 (Allan et al., 2003) . Therefore, all these considerations led us to the conclusion that parthenolide induces cell death through a caspase-independent mechanism.
Differently from cytochrome c, AIF has been shown to induce a caspase-independent mechanism in many circumstances. However it is uncertain at the moment whether AIF is present in the intermembrane space (Sevrioukova, 2011) or is inserted in the inner mitochondrial membrane (Arnoult et al., 2002; Otera et al., 2005) . In the first case permeabilization of the outer membrane could directly cause AIF release from mitochondria, while in the second case the cleavage of the protein by calpains is needed before AIF is released from mitochondria (Polster et al., 2005) . In both the cases AIF after its release translocates to the nucleus where it contributes to CC, high molecular weight DNA fragmentation, and nuclear shrinkage (Susin et al., 2000; Dawson and Dawson, 2004; Hong et al., 2004) . Taken together our data strongly suggest that AIF can be considered as an important mediator of cell death induced by parthenolide. This conclusion is based on the following evidences: First, immunofluorescence permitted to ascertain that after parthenolide treatment AIF co-localized in the nuclei with condensed chromatin. Second, down-regulation of AIF expression by specific siRNA markedly reduced the cytotoxic effectiveness of parthenolide; in fact parthenolide induced CC and fragmentation in a percentage of AIF-silenced cells, which was much lower than that ascertained in the control. A similar observation was also made for the cells showing necrotic-like aspects, which appeared in the second phase of treatment. Third, z-VAD-fmk was unable to prevent both parthenolide-induced cell death and AIF translocation to the nucleus. In addition observation that parthenolide stimulated mitochondrial calcium uptake is in accordance with the finding that Ca 2þ can induce calpain-dependent cleavage of AIF from the inner membrane (Norberg et al., 2008) .
The results reported in this article demonstrate that parthenolide rapidly caused dissipation of Dcm through ROS generation. Depolarization of mitochondrial membrane induced translocation of AIF to the nucleus (Pardo et al., 2001) with the consequent condensation of chromatin and nuclear shrinkage. These events occurred in the first phase of treatment (0-5 h). In the second phase of treatment (5-15 h) the content of ATP progressively lowered, reaching very low values at 12-15 h. Therefore, necrotic aspects became gradually prevalent and a high percentage of cells died for necrosis.
In conclusion this article shows that parthenolide induces cell death in human MG63 and SK-MEL-28 cells by activating a caspase-independent mechanism, which is mediated by AIF. In particular AIF seems to be responsible not only for CC but also for necrotic events. This is in accordance with recent reports showing that AIF plays a key role in programmed necrosis by its ability to organize a DNA-degrading complex (Artus et al., 2010; Baritaud et al., 2010) . Therefore, our article sheds new light on the mechanism by which parthenolide induced death of tumor cells and assigns to AIF the central role in the execution of this caspase-independent mechanism of programmed cell death.
